CA 19-9 ANTIGEN - ANVISA Registration 10339840129

Access comprehensive regulatory information for CA 19-9 ANTIGEN in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 10339840129 and manufactured by DIASORIN ITALIA S.P.A.. The registration is held by DIASORIN LTDA with validity until Dec 27, 2026.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including ABBOTT GMBH, ROCHE DIAGNOSTICS GMBH, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
10339840129
2 Related Devices
Registration Details
ANVISA Registration Number: 10339840129
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Related Devices (2)

LIAISON CA 19-9
Risk Class III

Registration Details

10339840129

253510201970162

01896764000170

Company Information

Italy
PT: ITÁLIA

Dates and Status

Dec 27, 2001

27/12/2026

09/18/2025 19:00:01

LIAISON CA 19-9
Risk Class III

Registration Details

10339840129

253510201970162

01896764000170

Company Information

Dates and Status

Dec 27, 2001

27/12/2026

09/18/2025 19:00:01